COMMUNIQUÉS West-GlobeNewswire

The Cooper Companies Announces Fourth Quarter and Full Year 2017 Results

07/12/2017 - 22:15

PLEASANTON, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced financial results for the fiscal fourth quarter and full year ended October 31, 2017. Fourth quarter revenue [...]

Intercept to Present at Upcoming Conference

07/12/2017 - 22:05

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock

07/12/2017 - 22:05

TUSTIN, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) (Nasdaq: PPHMP ) today announced that its Board of Directors has declared a quarterly cash dividend payment on the [...]

Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

07/12/2017 - 22:05

YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller [...]

Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

07/12/2017 - 22:05

AUSTIN, Texas, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]

Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer

07/12/2017 - 22:05

SAN ANTONIO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that tucatinib in combination with standard of care agents [...]

Fennec Announces Proposed Public Offering of Common Shares

07/12/2017 - 22:01

RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK™ (a unique formulation of sodium [...]

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

07/12/2017 - 21:00

COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full- [...]

BioInformatics LLC Expands Analyst Team and Customer Outreach

07/12/2017 - 20:12

ARLINGTON, Va., Dec. 07, 2017 (GLOBE NEWSWIRE) -- BioInformatics LLC announced a significant expansion of its Strategic Directions International (SDi) division to enhance the range of market research products and [...]

Tempus Unveils Tempus O, a Platform to Structure and Annotate Clinical Data at Scale

07/12/2017 - 18:22

CHICAGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data today announced the [...]

Annual General Meeting in Coloplast A/S - Election of own Chairman and Deputy Chairman

07/12/2017 - 17:31

See enclosed pdf.

Articles of Association for Coloplast A/S

07/12/2017 - 17:29

See enclosed pdf.

Annual General Meeting of Coloplast A/S

07/12/2017 - 17:26

The Annual General Meeting of Coloplast A/S has just been adjourned. See the report on transactions in the enclosed pdf. The report is attached in Danish and English.

Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology

07/12/2017 - 16:36

Presentation of Posters by Expert Scientists Now Available On-Demand on Crown Bioscience’s Website https://www.crownbio.com/eortc17-posters SANTA CLARA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a [...]

Hospitals Save Lives and Money by Investing in Climate Resilience

07/12/2017 - 16:08

BOSTON, Dec. 07, 2017 (GLOBE NEWSWIRE) -- In the wake of costly storms and wildfires in 2017, health care leaders can safeguard lives and their organization's financial viability by investing in climate resilience, [...]

Exergen Reaches New Milestone: Temporal Artery Thermometers Now Used by More Nurses Than Any Other Type of Thermometer

07/12/2017 - 15:52

WATERTOWN, Mass., Dec. 07, 2017 (GLOBE NEWSWIRE) -- A recent survey reveals that over 50% of nurses in the U.S. use a temporal artery thermometer professionally - more than oral (48%), rectal (13%), axillary (23%), and [...]

Medical Society of Delaware Partners with HealthEC To Provide Population Health Platform to Nearly 900 Physicians

07/12/2017 - 15:37

NEWARK, Del. and PISCATAWAY, N.J., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Medical Network Management Services of Delaware, LLC (MedNet) , a wholly-owned subsidiary of the Medical Society of Delaware (MSD) , has awarded a [...]

Zealand Pharma initiates the pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes

07/12/2017 - 15:36

Company announcement - No. 55/2017 Zealand Pharma initiates the pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes First patient recruited in the second Phase 3 clinical trial [...]

Cannabix Technologies Inc. Closes $4.6 Million Bought Deal Private Placement and $977,500 Concurrent Non-Brokered Private Placement

07/12/2017 - 15:07

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (the “Company”) is pleased to [...]